Literature DB >> 10790116

Distinguishing species of the Burkholderia cepacia complex and Burkholderia gladioli by automated ribotyping.

S Brisse1, C M Verduin, D Milatovic, A Fluit, J Verhoef, S Laevens, P Vandamme, B Tümmler, H A Verbrugh, A van Belkum.   

Abstract

Several species belonging to the genus Burkholderia are clinically relevant, opportunistic pathogens that inhabit major environmental reservoirs. Consequently, the availability of means for adequate identification and epidemiological characterization of individual environmental or clinical isolates is mandatory. In the present communication we describe the use of the Riboprinter microbial characterization system (Qualicon, Warwick, United Kingdom) for automated ribotyping of 104 strains of Burkholderia species from diverse sources, including several publicly accessible collections. The main outcome of this analysis was that all strains were typeable and that strains of Burkholderia gladioli and of each species of the B. cepacia complex, including B. multivorans, B. stabilis, and B. vietnamiensis, were effectively discriminated. Furthermore, different ribotypes were discerned within each species. Ribotyping results were in general agreement with strain classification based on restriction fragment analysis of 16S ribosomal amplicons, but the resolution of ribotyping was much higher. This enabled automated molecular typing below the species level. Cluster analysis of the patterns obtained by ribotyping (riboprints) showed that within B. gladioli, B. multivorans, and B. cepacia genomovar VI, the different riboprints identified always clustered together. Riboprints of B. cepacia genomovars I and III, B. stabilis, and B. vietnamiensis did not show distinct clustering but rather exhibited the formation of loose assemblages within which several smaller, genomovar-specific clusters were delineated. Therefore, ribotyping proved useful for genomovar identification. Analysis of serial isolates from individual patients demonstrated that infection with a single ribotype had occurred, despite minor genetic differences that were detected by pulsed-field gel electrophoresis of DNA macrorestriction fragments. The automated approach allows very rapid and reliable identification and epidemiological characterization of strains and generates an easily manageable database suited for expansion with information on additional bacterial isolates.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10790116      PMCID: PMC86613     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  41 in total

1.  Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity.

Authors:  P R Hunter; M A Gaston
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

2.  Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis.

Authors:  J C Christenson; D F Welch; G Mukwaya; M J Muszynski; R E Weaver; D J Brenner
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

3.  Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCR.

Authors:  A Bauernfeind; I Schneider; R Jungwirth; C Roller
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

4.  Use of automated ribotyping of Austrian Listeria monocytogenes isolates to support epidemiological typing.

Authors:  F Allerberger; S J Fritschel
Journal:  J Microbiol Methods       Date:  1999-04       Impact factor: 2.363

5.  Ribotype stability of serial pulmonary isolates of Pseudomonas cepacia.

Authors:  J J LiPuma; M C Fisher; S E Dasen; J E Mortensen; T L Stull
Journal:  J Infect Dis       Date:  1991-07       Impact factor: 5.226

6.  Lipopolysaccharide chemotypes of Burkholderia cepacia.

Authors:  Elwyn Evans; Ian R Poxton; John R W Govan
Journal:  J Med Microbiol       Date:  1999-09       Impact factor: 2.472

7.  Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.

Authors:  A Isles; I Maclusky; M Corey; R Gold; C Prober; P Fleming; H Levison
Journal:  J Pediatr       Date:  1984-02       Impact factor: 4.406

8.  Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov.

Authors:  E Yabuuchi; Y Kosako; H Oyaizu; I Yano; H Hotta; Y Hashimoto; T Ezaki; M Arakawa
Journal:  Microbiol Immunol       Date:  1992       Impact factor: 1.955

9.  Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. Summer Camp Study Group.

Authors:  D A Pegues; L A Carson; O C Tablan; S C FitzSimmons; S B Roman; J M Miller; W R Jarvis
Journal:  J Pediatr       Date:  1994-05       Impact factor: 4.406

10.  Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis.

Authors:  S Steinbach; L Sun; R Z Jiang; P Flume; P Gilligan; T M Egan; R Goldstein
Journal:  N Engl J Med       Date:  1994-10-13       Impact factor: 91.245

View more
  9 in total

1.  Automated ribotyping provides rapid phylogenetic subgroup affiliation of clinical extraintestinal pathogenic Escherichia coli strains.

Authors:  O Clermont; C Cordevant; S Bonacorsi; A Marecat; M Lange; E Bingen
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

2.  Comparative evaluation of the BD Phoenix and VITEK 2 automated instruments for identification of isolates of the Burkholderia cepacia complex.

Authors:  Sylvain Brisse; Stefania Stefani; Jan Verhoef; Alex Van Belkum; Peter Vandamme; Wil Goessens
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

Review 3.  Taxonomy and identification of the Burkholderia cepacia complex.

Authors:  T Coenye; P Vandamme; J R Govan; J J LiPuma
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

4.  Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice.

Authors:  U Sajjan; G Thanassoulis; V Cherapanov; A Lu; C Sjolin; B Steer; Y J Wu; O D Rotstein; G Kent; C McKerlie; J Forstner; G P Downey
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

5.  Automated ribotyping of vancomycin-resistant Enterococcus faecium isolates.

Authors:  Sylvain Brisse; Vivian Fussing; Ben Ridwan; Jan Verhoef; Rob J L Willems
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

6.  PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients.

Authors:  A McDowell; E Mahenthiralingam; J E Moore; K E Dunbar; A K Webb; M E Dodd; S L Martin; B C Millar; C J Scott; M Crowe; J S Elborn
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

7.  Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. using automated ribotyping.

Authors:  S Brisse; D Milatovic; A C Fluit; K Kusters; A Toelstra; J Verhoef; F J Schmitz
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

8.  Comparison of rapid, automated ribotyping and DNA macrorestriction analysis of Burkholderia pseudomallei.

Authors:  Timothy J J Inglis; Lyn O'Reilly; Niki Foster; Adele Clair; Judy Sampson
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

9.  Species distribution and ribotype diversity of Burkholderia cepacia complex isolates from French patients with cystic fibrosis.

Authors:  Sylvain Brisse; Christophe Cordevant; Peter Vandamme; Philippe Bidet; Chawki Loukil; Gérard Chabanon; Marc Lange; Edouard Bingen
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.